Protein expression profiles indicative for drug resistance of non-small cell lung cancer

被引:0
|
作者
M Volm
R Koomägi
J Mattern
T Efferth
机构
[1] German Cancer Research Centre,
[2] Virtual Campus Rhineland-Palatinate,undefined
来源
British Journal of Cancer | 2002年 / 87卷
关键词
non-small cell lung carcinomas; resistance factors; hierarchical cluster analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Data obtained from multiple sources indicate that no single mechanism can explain the resistance to chemotherapy exhibited by non-small cell lung carcinomas. The multi-factorial nature of drug resistance implies that the analysis of comprising expression profiles may predict drug resistance with higher accuracy than single gene or protein expression studies. Forty cellular parameters (drug resistance proteins, proliferative, apoptotic, and angiogenic factors, products of proto-oncogenes, and suppressor genes) were evaluated mainly by immunohistochemistry in specimens of primary non-small cell lung carcinoma of 94 patients and compared with the response of the tumours to doxorubicin in vitro. The protein expression profile of non-small cell lung carcinoma was determined by hierarchical cluster analysis and clustered image mapping. The cluster analysis revealed three different resistance profiles. The frequency of each profile was different (77, 14 and 9%, respectively). In the most frequent drug resistance profile, the resistance proteins P-glycoprotein/MDR1 (MDR1, ABCB1), thymidylate-synthetase, glutathione-S-transferase-π, metallothionein, O6-methylguanine-DNA-methyltransferase and major vault protein/lung resistance-related protein were up-regulated. Microvessel density, the angiogenic factor vascular endothelial growth factor and its receptor FLT1, and ECGF1 as well were down-regulated. In addition, the proliferative factors proliferating cell nuclear antigen and cyclin A were reduced compared to the sensitive non-small cell lung carcinoma. In this resistance profile, FOS was up-regulated and NM23 down-regulated. In the second profile, only three resistance proteins were increased (glutathione-S-transferase-π, O6-methylguanine-DNA-methyltransferase, major vault protein/lung resistance-related protein). The angiogenic factors were reduced. In the third profile, only five of the resistance factors were increased (MDR1, thymidylate-synthetase, glutathione-S-transferase-π, O6-methylguanine-DNA-methyltransferase, major vault protein/lung resistance-related protein).
引用
收藏
页码:251 / 257
页数:6
相关论文
共 50 条
  • [22] Protein profiles correlated with recurrence of early stage non-small cell lung cancer
    Lu, Zhe-ming
    Hong, Shao-lin
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (01) : 21 - 26
  • [24] Analysis for the mechanism between the small cell lung cancer and non-small cell lung cancer combing the miRNA and mRNA expression profiles
    Zhang, Weisan
    Zhang, Qiang
    Zhang, Mingpeng
    Zhang, Yun
    Li, Fengtan
    Lei, Ping
    THORACIC CANCER, 2015, 6 (01) : 70 - 79
  • [25] Calcineurin Homologous Protein 2 Expression in Non-Small Cell Lung Cancer
    Tran, Michelle
    Cain, Michael
    Wallert, Michael
    Provost, Joseph
    FASEB JOURNAL, 2015, 29
  • [26] Protein Expression in Human Non-Small Cell Lung Cancer: A Systematic Database
    Buehrens, Rena Isabel
    Amelung, Julius Titus
    Reymond, Marc Andre
    Beshay, Morris
    PATHOBIOLOGY, 2009, 76 (06) : 277 - 285
  • [27] MiRNA expression in non-small cell lung cancer
    Petkova, Veronika
    Marinova, Dora
    Kyurkchiyan, Silva
    Stancheva, Gergana
    Mekov, Evgeni
    Kachakova-Yordanova, Darina
    Slavova, Yanina
    Kostadinov, Dimitar
    Mitev, Vanyo
    Kaneva, Radka
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 540 - 540
  • [28] Expression of thrombospondin in non-small cell lung cancer
    Mascaux, C
    Martin, B
    Paesmans, M
    Verdebout, J
    Verhest, A
    Vermylen, P
    Bosschaerts, T
    Ninane, V
    Sculier, JP
    ANTICANCER RESEARCH, 2002, 22 (2B) : 1273 - 1277
  • [29] Angiostatin expression in non-small cell lung cancer
    Volm, M
    Mattern, J
    Koomägi, R
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3236 - 3240
  • [30] Vinculin expression in non-small cell lung cancer
    Yu, Qiuli
    Xu, Liqin
    Chen, Long
    Sun, Baier
    Yang, Zhiyun
    Lu, Kunqin
    Yang, Zhiyong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (01)